Search
Selected Filter
Displaying 111–120 of 512 news results
-
Research News
Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the United States and 5 million worldwide.
This is the first time that a treatment has been approved for this leading cause of blindness.
-
The Foundation Makes an Impact on Retinal Research
Foundation NewsThe Foundation Fighting Blindness’ long-term impact on moving the inherited retinal disease field forward towards treatments and cures.
-
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
Foundation NewsSession to have special translational research emphasis on PRPH2 and inherited macular dystrophies.
-
The Retinal Degeneration Fund invests in a $78M Series B for Perceive Biotherapeutics
In the PressThe investment supports the clinical development of two novel programs, both with the aim of being protective against vision loss.
-
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
Research NewsThe company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
Research NewsThe emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
-
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Research NewsThe LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Your Dollar Makes a Difference
Foundation NewsAt the Foundation Fighting Blindness, a dollar is more than just a dollar – it’s a path to transforming lives. But just where does your donation go?
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Research NewsThe company is seeking a partner to move the LCA10 program forward
-
Foundation News
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
.png)
